RecruitingNCT07483294
Brain scans and treatment response in first-episode psychosis
About this title
Read the official source — NCT07483294Medication studyAges 15–40United StatesSchizophrenia
Understand this study
Who could participate?
Listed age limits: 15 years to 40 years.
- Listed locations
- Glen OaksSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: November 1, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 120
- Sponsor
- Northwell Health
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 15 Years to 40 Years
- Official registry ID
- NCT07483294
- Official title
Show the full official title
Cerebellar-cortical Circuitry and Prediction of Treatment Response in Early Psychosis
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Glen Oaks
Questions about this study
Who is behind this study?
The study sponsor is Northwell Health.
Does this study involve medication?
Yes. The study involves medication, including risperidone and aripiprazole.
Who can participate?
Listed age limits: 15 years to 40 years.
Is this study still recruiting?
The registry lists this study as recruiting.
